An alternative model for genetic testing delivery proposed with posttest counselling for those with pathogenic variants and on demand for those without pathogenic variants

 Findings from MAGENTA (Making Genetic Testing Accessible), the first randomized clinical study "evaluating the effect of individualized pretest and posttest counselling for cancer risk assessment while providing electronic enrolment, remote testing, and counselling" was recently published in JAMA Oncology.  

Of the 3839 women, ranging in age from 22-91 (average age: 44) included in the MAGENTA study, study authors concluded that alternative models of genetic counselling, such as telehealth, which became particularly prevalent during the COVID-19 pandemic, "provides more flexibility for patients and reduces costs."  

To learn more about the MAGENTA study, click here. 

Source mentioned:  Swisher EM, Rayes N, Bowen D, et al. Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial A Randomized Clinical Trial. JAMA Oncology; Published online 14 September 2023. doi:10.1001/jamaoncol.2023.3748